Impact of polyunsaturated fatty acids on hepato-pancreatic prostaglandin and leukotriene concentration in ductal pancreatic cancer-Is there a correlation to tumour growth and liver metastasis?

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 74, Issue 4, 2006, Pages 223-233

  Heukamp, I ^a   Kilian, M ^b   Gregor, J I ^b   Kiewert, C ^b   Schimke, I ^c   Kristiansen, G ^d   Walz, M K ^e   Jacobi, C A ^b   Wenger, F A ^e  

^a Clinic of Internal Medicine IV (Prof Dr H Lochs)   (Germany)

^b Visceral   (Germany)

^c Clinic of Internal Medicine I (Prof Dr G Baumann)   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e KLINIKEN ESSEN MITTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; LEUKOTRIENE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HAMSTER; HISTOLOGY; INCIDENCE; LIPID COMPOSITION; LIPID DIET; LIVER; LIVER METASTASIS; MALE; NONHUMAN; PANCREAS; PANCREAS CANCER; PANCREAS CARCINOMA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; CRICETINAE; DIETARY FATS, UNSATURATED; DINOPROST; DINOPROSTONE; FATTY ACIDS, UNSATURATED; LEUKOTRIENES; LIVER; LIVER NEOPLASMS; MALE; PANCREAS; PANCREATIC NEOPLASMS; PROSTAGLANDINS;

ANIMALIA; CRICETINAE;

EID: 33646113159     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.01.005     Document Type: Article

References (48)

1. Rosenberg L. Pancreatic cancer: a review of emerging therapies. Drugs 59 5 (2000) 1071-1089
2. Gunzburg W.H., and Salmons B. Novel clinical strategies for the treatment of pancreatic carcinoma. Trends Mol. Med. 7 1 (2001) 30-37
3. Eskelinen M.J., and Haglund U.H. Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods. Eur. J. Surg. 165 4 (1999) 292-306
4. Kleeff J., Friess H., Berberat P.O., Martignoni M.E., Zgraggen K., and Büchler M.W. Pancreatic cancer-new aspects of molecular biology research. Swiss Surg. 6 5 (2000) 231-234
5. Gebauer T., Ridwelski K., Fahlke J., and Lippert H. Locoregional and systemic therapy of advanced pancreatic carcinoma. Langenbecks Arch. Chir. Suppl. Kongressbd. 115 (1998) 1344-1347
6. Cooperman A.M. Pancreatic cancer: the bigger picture. Surg. Clin. North Am. 81 3 (2001) 557-574
7. Sohn T.A., Yeo C.J., Cameron J.L., Koniaris L., Kaushal S., Abrams R.A., Sauter P.K., Coleman J., Hruban R.H., and Lillemoe K.D. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J. Gastrointest. Surg. 4 6 (2000) 567-579
8. Ridwelski K., Meyer F., Ebert M., Malfertheiner P., and Lippert H. Prognostic parameters determining survival in pancreatic carcinoma and, in particular, after palliative treatment. Dig. Dis. 19 1 (2001) 85-92
9. Cubiella J., Castells A., Fondevila C., Sans M., Sabater L., Navarro S., and Fernandez-Cruz L. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials. Am. J. Gastroenterol. 94 5 (1999) 1271-1278
10. Cooperman A.M., Kini S., Snady H., Bruckner H., and Chamberlain R.S. Current surgical therapy for carcinoma of the pancreas. J. Clin. Gastroenterol. 31 2 (2000) 107-113
11. Ravichandran D., Cooper A., and Johnson C.D. Effect of 1-(gamma)linolenyl-3-eicospentaenoyl propane diol on the growth of human pancreatic carcinoma in vitro and in vivo. Eur. J. Cancer 36 3 (2000) 423-427
12. Woutersen R.A., Appel M.J., van Garderen-Hoetmer A., and Wijnands M.V. Dietary fat and carcinogenesis. Mutat. Res. 443 1-2 (1999) 111-127
13. De Antueno R., Bai M., and Elliot M. Tissue distribution and metabolism of gamma-linoenoyl-3-eicosapentaenoyl propane diol enterally or intravenously administered to mice bearing human pancreatic carcinomas. Anticancer Res. 19 3A (1999) 2041-2048
14. Hawkins R.A., Sangster K., and Arends M.J. Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J. Pathol. 185 1 (1998) 61-70
15. Wigmore S.J., Fearon K.C., Maingay J.P., and Ross J.A. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin. Sci. (London) 92 2 (1997) 215-221
16. Ravichandran D., Cooper A., and Johnson C.D. Effect of lithium gamma-linolenate on the growth of experimental human pancreatic carcinoma. Br. J. Surg. 85 9 (1998) 1201-1205
17. Noguchi M., Rose D.P., Earashi M., and Miyazaki I. The role of fatty acids and eicosanoid synthesis inhibitors in breast carcinoma. Oncology 52 4 (1995) 265-271
18. Appel M.J., van Garderen-Hoetmer A., and Woutersen R.A. Effect of dietary linoleic acid on pancreatic carcinogenesis in rats and hamsters. Cancer Res. 54 (1994) 2113-2120
19. Damtew B., and Spagnuolo P.J. Tumour cell-endothelial cell interactions: evidence for roles for lipoxygenase products of arachidonic acid in metastasis. Prostaglandins Leukot. Essent. Fatty Acids 56 4 (1997) 295-300
20. Hong S.H., Avis I., Vos M.D., Martínez A., Treston A.M., and Mulshine J.L. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Cancer Res. 59 (1999) 2223-2228
21. Reich R., and Martin G.R. Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumour cells. Prostaglandins 51 1 (1996) 1-17
22. Roebuck B.D. Dietary fat and the development of pancreatic cancer. Lipids 27 10 (1992) 804-806
23. Schonberg S., and Krokan H.E. The inhibitory effect of conjugated dienoic derivates (CLA) of linoleic acid on the tumour growth of human tumour cell lines is in part due to increased lipid peroxidation. Anticancer Res. 15 (1995) 1241-1246
24. UKCCCR-Guidelines for the welfare of animals in experimental neoplasia. Cancer Metast. Rev. 8 (1989) 82-88
25. New York Academy of Sciences' Ad Hoc Committee on Animal Research. Interdisciplinary principles and guidelines for the use of animals in research, marketing and education.
26. Meijers M., van Garderen-Hoetmer A., Lamers C.B., Rovati L.C., Jansen J.B., and Woutersen R.A. Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters. Carcinogenesis 11 (1990) 2223-2226
27. Appel M.J., and Woutersen R.A. Dietary fish oil (MaxEPA) enhances pancreatic carcinogenesis in azaserine-treated rats. Br. J. Cancer 73 (1996) 36-43
28. Wenger F.A., Jacobi C.A., Kilian M., Zieren J., and Zieren H.U. Does dietary α-linoleic acid promote liver metastases in pancreatic carcinoma initiated by BOP in Syrian hamsters?. Ann. Nutr. Metab. 43 (1999) 121-126
29. Rao C.V., Hirose Y., Indranie C., and Reddy B.S. Modulation of experimental colon tumourigenesis by types and amounts of dietary fatty acids. Cancer Res. 61 5 (2001) 1927-1933
30. Mori T., Imaida K., Tamano S., Sano M., Takahashi S., Asamoto M., Takeshita M., Ueda H., and Shirai T. Beef tallow, but not perilla or corn oil, promotion of rat prostate and intestinal carcinogenesis by 3,2′-dimethyl-4-aminobiphenyl. Jpn. J. Cancer Res. 92 10 (2001) 1026-1033
31. Calviello G., Palozza P., Franceschelli P., Frattuci A., Piccioni E., Tessitore L., and Bartoli G.M. Eicosapentaenoic acid inhibits the growth of liver preneoplastic lesions and alters membrane phopholipid composition and peroxisomal beta-oxidation. Nutr. Cancer 34 2 (1999) 206-212
32. Kontogiannea M., Gupta A., Ntanios F., Graham T., Jones P., and Meterissian S. Omega-3 fatty acids decrease endothelial adhesion of human colorectal carcinoma cells. J. Surg. Res. 92 2 (2000) 201-205
33. Toriyama-Baba H., Iigo M., Asamoto M., Iwahori Y., Park C.B., Han B.S., Takasuka N., Kakizoe T., Ishikawa C., Yazawa K., Araki E., and Tsuda H. Organotropic chemopreventive effects of n-3 unsaturated fatty acids in a rat multi-organ carcinogenesis model. Jpn. J. Cancer Res. 92 11 (2001) 1175-1183
34. Chung B.H., Mitchell S.H., Zhang J.S., and Young C.Y. Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells. Carcinogenesis 22 8 (2001) 1201-1206
35. Bougnoux P. n-3 polyunsaturated fatty acids and cancer. Curr. Opin. Clin. Nutr. Metab. Care 2 2 (1999) 121-126
36. Farrow B., and Evers B.M. Inflammation and the development of pancreatic cancer. Surg. Oncol. 10 4 (2002) 153-169
37. Wenger F.A., Kilian M., Jacobi C.A., Schimke I., Guski H., and Müller J.M. Does α-linolenic acid in combination with linoleic acid influence liver metastasis and hepatic lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters?. Prostaglandins Leukot. Essent. Fatty Acids 62 (2000) 329-334
38. Tucker O.N., Dannenberg A.J., Yang E.K., Zhang F., Teng L., Daly J.M., Soslow R.A., Masferrer J.L., Woerner B.M., Koki A.T., and Fahey III T.J. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res. 59 (1999) 987-990
39. Pariza M.W., Ha Y.L., Benjamin H., Sword J.T., Grüter A., Chin S.F., Storkson J., Faith N., and Albright K. Formation and action of anticarcinogenic fatty acids. Nutr. Toxicol. Cons. Food Proc. (1991) 269-273
40. Kuratko C.N. Proliferation of colonic lymphocytes in response to inflammatory cytokines is lower in mice fed fish oil than in mice fed corn oil. Cancer Lett. 148 1 (2000) 27-32
41. Takahashi M., Fukutake M., Isoi T., Fukuda K., Sato H., Yazawa K., Sugimura T., and Wakabayashi K. Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). Carcinogenesis 18 7 (1997) 1337-1342
42. Sala A., and Folco G. Neutrophils, endothelial cells, and cysteinyl leukotrienes: a new approach to neutrophil-dependent inflammation?. Biochem. Biophys. Res. Commun. 283 5 (2001) 1003-1006
43. Cuendet M., and Pezzuto J.M. The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol. Drug Interact. 1-4 (2000) 109-157
44. Shureiqi I., and Lippman S.M. Lipoxygenase modulation to reverse carcinogenesis. Cancer Res. 61 17 (2001) 6307-6312
45. Lupulescu A. Prostaglandins, their inhibitors and cancer. Prostaglandins Leukot. Essent. Fatty Acids 54 2 (1996) 83-94
46. Ding X.Z., Kuszynski C.A., El-Metwally T.H., and Adrian T.E. Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells. Biochem. Biophys. Res. Commun. 226 2 (1999) 392-399
47. Ohd J.F., Wikstrom K., and Sjolander A. Leukotrienes induce cell-survival signaling in intestinal epithelial cells. Gastroenterology 119 4 (2000) 1007-1018
48. Takahashi M., Furukawa F., Toyoda K., Sato H., Hasegawa R., Imaida K., and Hayashi Y. Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis (2-oxopropyl) amine. Carcinogenesis 11 3 (1990) 393-395